METAL NON-COVERED BILIARY STENT MARKET ANALYSIS

Market News

Global Metal Non-covered Biliary Stent Market- Key Developments

In May 2021, Cook, a medical device company that develops, manufactures, and distributes devices for minimally invasive medicine, acquired Cantel Medical, a global company that provides innovative infection prevention products and services for patients, to expand its biliary stent and another product portfolio to provide services to customers globally. Thus, such development in the region is likely to boost demand for pancreatic and biliary stents.

On February 24, 2023, Olympus Corporation, a global medtech company that makes  people’s lives healthier, safer, and more fulfilling, acquired Taewoong Medical Co., Ltd, (Taewoong Medical), a manufacturer of medical devices such as gastrointestinal (GI) metallic stents1, to strengthen its GI EndoTherapy product portfolio capabilities, and thus, improving patient outcome through comprehensive solutions. Taewoong Medical will receive approximately US$ 370 million in cash, out of which, US$ 255.5 million will be paid at the closing and up to US$ 114.5 million will be paid if future milestones is achieved.

In May 2021, AMG International, a wholly owned subsidiary Q3 Medical Devices Limited (Q3), an Ireland-based company which deals with the innovation of biodegradable implants and micro invasive technology, further established its leadership role in the fast-paced development of novel biodegradable implants. The company announced that it had received CE Mark approval for its second fully biodegradable product named UNITY-B balloon expandable biodegradable biliary stent (BEBS) for endoscopic use. The UNITY-B will compliment ARCHIMEDES, the world's first CE approved pancreatico biliary biodegradable implant.

In May 2020, Q3 Medical Group, a medical device company entered a distribution agreement with Medtronic, a medical device company for its AECHIMEDES, a biodegradable biliary and pancreatic stent. This stent is specially designed as an alternative to the traditional plastic biliary stents. The aim behind this six-year exclusive agreement is to distribute ARCHIMEDES biodegradable stent in the western EU, Japan, and the U.S. with rights to other regions.

Global Metal Non-covered Biliary Stent Market- Key Trends

Partnership by the Key Players

Key players are focusing on collaboration as well as partnership, for the market growth over the forecast period. In July 2022, Micro-Tech Endoscopy, a global manufacturer of GI endoscopy devices and non-vascular stents, announced a distribution partnership with Thoracent, Inc., an innovator in pulmonology.  Thoracent, Inc. will be the U.S. distributor of Micro-Tech's Y-Shaped tracheal biliary stent system, a flexible, self-expanding device with an innovative over-the-wire delivery system that is designed to aid the management of airway tumors in the trachea without invasive surgery.